Identification of Novel Candidate Epitopes on SARS-CoV-2 Proteins for South America: A Review of HLA Frequencies by Country
- PMID: 33013857
- PMCID: PMC7494848
- DOI: 10.3389/fimmu.2020.02008
Identification of Novel Candidate Epitopes on SARS-CoV-2 Proteins for South America: A Review of HLA Frequencies by Country
Abstract
Coronavirus disease (COVID-19), caused by the virus SARS-CoV-2, is already responsible for more than 4.3 million confirmed cases and 295,000 deaths worldwide as of May 15, 2020. Ongoing efforts to control the pandemic include the development of peptide-based vaccines and diagnostic tests. In these approaches, HLA allelic diversity plays a crucial role. Despite its importance, current knowledge of HLA allele frequencies in South America is very limited. In this study, we have performed a literature review of datasets reporting HLA frequencies of South American populations, available in scientific literature and/or in the Allele Frequency Net Database. This allowed us to enrich the current scenario with more than 12.8 million data points. As a result, we are presenting updated HLA allelic frequencies based on country, including 91 alleles that were previously thought to have frequencies either under 5% or of an unknown value. Using alleles with an updated frequency of at least ≥5% in any South American country, we predicted epitopes in SARS-CoV-2 proteins using NetMHCpan (I and II) and MHC flurry. Then, the best predicted epitopes (class-I and -II) were selected based on their binding to South American alleles (Coverage Score). Class II predicted epitopes were also filtered based on their three-dimensional exposure. We obtained 14 class-I and four class-II candidate epitopes with experimental evidence (reported in the Immune Epitope Database and Analysis Resource), having good coverage scores for South America. Additionally, we are presenting 13 HLA-I and 30 HLA-II novel candidate epitopes without experimental evidence, including 16 class-II candidates in highly exposed conserved areas of the NTD and RBD regions of the Spike protein. These novel candidates have even better coverage scores for South America than those with experimental evidence. Finally, we show that recent similar studies presenting candidate epitopes also predicted some of our candidates but discarded them in the selection process, resulting in candidates with suboptimal coverage for South America. In conclusion, the candidate epitopes presented provide valuable information for the development of epitope-based strategies against SARS-CoV-2, such as peptide vaccines and diagnostic tests. Additionally, the updated HLA allelic frequencies provide a better representation of South America and may impact different immunogenetic studies.
Keywords: COVID-19; HLA; SARS-CoV-2; South America; allele frequency; epitope; immunoinformatics; literature review.
Copyright © 2020 Requena, Médico, Chacón, Ramírez and Marín-Sánchez.
Figures




Similar articles
-
Bioinformatics analysis of epitope-based vaccine design against the novel SARS-CoV-2.Infect Dis Poverty. 2020 Jul 10;9(1):88. doi: 10.1186/s40249-020-00713-3. Infect Dis Poverty. 2020. PMID: 32741372 Free PMC article.
-
Epitope-based peptide vaccines predicted against novel coronavirus disease caused by SARS-CoV-2.Virus Res. 2020 Oct 15;288:198082. doi: 10.1016/j.virusres.2020.198082. Epub 2020 Jul 1. Virus Res. 2020. PMID: 32621841 Free PMC article.
-
Immunoinformatics-guided designing of epitope-based subunit vaccines against the SARS Coronavirus-2 (SARS-CoV-2).Immunobiology. 2020 May;225(3):151955. doi: 10.1016/j.imbio.2020.151955. Epub 2020 May 11. Immunobiology. 2020. PMID: 32517882 Free PMC article.
-
Immune and bioinformatics identification of T cell and B cell epitopes in the protein structure of SARS-CoV-2: A systematic review.Int Immunopharmacol. 2020 Sep;86:106738. doi: 10.1016/j.intimp.2020.106738. Epub 2020 Jun 28. Int Immunopharmacol. 2020. PMID: 32683296 Free PMC article.
-
New insights on possible vaccine development against SARS-CoV-2.Life Sci. 2020 Nov 1;260:118421. doi: 10.1016/j.lfs.2020.118421. Epub 2020 Sep 11. Life Sci. 2020. PMID: 32926920 Free PMC article. Review.
Cited by
-
Immunoinformatics Approach for Epitope-Based Vaccine Design: Key Steps for Breast Cancer Vaccine.Diagnostics (Basel). 2022 Nov 28;12(12):2981. doi: 10.3390/diagnostics12122981. Diagnostics (Basel). 2022. PMID: 36552988 Free PMC article. Review.
-
The influence of HLA genotype on the severity of COVID-19 infection.HLA. 2021 Jul;98(1):14-22. doi: 10.1111/tan.14284. Epub 2021 May 4. HLA. 2021. PMID: 33896121 Free PMC article.
-
Immunoinformatics Analysis of SARS-CoV-2 ORF1ab Polyproteins to Identify Promiscuous and Highly Conserved T-Cell Epitopes to Formulate Vaccine for Indonesia and the World Population.Vaccines (Basel). 2021 Dec 9;9(12):1459. doi: 10.3390/vaccines9121459. Vaccines (Basel). 2021. PMID: 34960205 Free PMC article.
-
DNA vaccine targeting betacoronavirus spike protein blocks neuroinvasion and neuroinflammation in swine via dual antiviral-immunomodulatory action.NPJ Vaccines. 2025 Aug 7;10(1):187. doi: 10.1038/s41541-025-01247-1. NPJ Vaccines. 2025. PMID: 40774966 Free PMC article.
-
The effect of the earliest COVID-19 outbreak on survival in uninfected advanced NSCLC patients receiving chemotherapy in Jiangsu Province, China: A retrospective cohort study.Medicine (Baltimore). 2023 Sep 29;102(39):e34559. doi: 10.1097/MD.0000000000034559. Medicine (Baltimore). 2023. PMID: 37773874 Free PMC article.
References
-
- World Health Organization WHO Director-General's Opening Remarks at the Media Briefing on COVID-19 - 11 March 2020. (2020). Available online at: https://www.who.int/dg/speeches/detail/who-director-general-s-opening-re... (accessed April 5, 2020).
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous